A novel structural framework for α(1A/D)-adrenoceptor selective antagonists identified using subtype selective pharmacophores (Q28478109)

1

0 references

Sevvandi Senadheera

2

0 references

Iain J A MacDougall

3

0 references

Renate Griffith

Creative Commons Attribution 4.0 International

4

0 references

language of work or name

English

0 references

publication date

10 May 2011

0 references

published in

PLOS One

0 references

volume

6

0 references

issue

5

0 references

page(s)

e19695

0 references

copyright license

start time

10 May 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pharmacological pleiotropism of the human recombinant α1A‐adrenoceptor: implications for α1‐adrenoceptor classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

(-)-Discretamine, a selective alpha 1D-adrenoceptor antagonist, isolated from Fissistigma glaucescens

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Recent advances in selective alpha1-adrenoreceptor antagonists as antihypertensive agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Alpha1-adrenoceptor subtypes and lower urinary tract symptoms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Virtual ligand screening: strategies, perspectives and limitations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Comparison of class A and D G protein-coupled receptors: common features in structure and activation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Drug design strategies for targeting G-protein-coupled receptors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Transgenic studies of alpha(1)-adrenergic receptor subtype function

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Alpha-adrenoceptor subtypes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Ligand design for alpha(1) adrenoceptors.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed [...]

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Synthesis and biological affinity of new imidazo- and indol-arylpiperazine derivatives: further validation of a pharmacophore model for alpha(1)-adrenoceptor antagonists

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Responses to noxious stimuli in mice lacking α1d-adrenergic receptors

2 June 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

Decreased exploratory activity and impaired passive avoidance behaviour in mice deficient for the alpha(1b)-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

Characteristics of behavioral abnormalities in alpha1d-adrenoceptors deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

Selective pharmacophore design for alpha1-adrenoceptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

Role of the alpha1D-adrenergic receptor in the development of salt-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity toward alpha(1)- and alpha(2)-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

Synthesis and biological activity of new 1,4-benzodioxan-arylpiperazine derivatives. Further validation of a pharmacophore model for alpha(1)-adrenoceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

alpha(1)-Adrenoceptor antagonists. Rational design, synthesis and biological evaluation of new trazodone-like compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

Pharmacophore identification of alpha(1A)-adrenoceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

8-NH2-boldine, an antagonist of alpha1A and alpha1B adrenoceptors without affinity for the alpha1D subtype: structural requirements for aporphines at alpha1-adrenoceptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

Ligand design for α 1 adrenoceptor subtype selective antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0019695

Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the alpha 1B-adrenergic receptor

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091868

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

27 November 2018

1 reference

12 December 2020

The alpha 1D-adrenergic receptor modulates cardiovascular and drinking responses to central salt loading in mice

1 reference

12 December 2020

Alpha1-adrenergic receptor subtypes in human detrusor

1 reference

12 December 2020

A multi-well filtration assay for quantitation of inositol phosphates in biological samples

1 reference

12 December 2020